By incorporating the Glu‐urea‐Lys unit as a specific PSMA binding moiety into the FC‐NEt2 molecule skeleton, the obtained FC‐PSMA probe exhibited a high fluorescence quantum yield (2.52%) in FBS and precise targeting recognition of prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.